Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group

Early Changes in Breast Cancer Blood Flow due to Chemotherapy: Potential Predictor for Therapeutic Efficacy

Not Accessible

Your library or personal account may give you access

Abstract

Preliminary results on human subjects with breast cancer undergoing neoadjuvant chemotherapy suggest early changes in blood flow measured with diffuse correlation spectroscopy may serve as a potential predictor for therapeutic efficacy.

© 2012 Optical Society of America

PDF Article
More Like This
Breast Cancer Therapy Monitoring with Diffuse Optical Tomography and Diffuse Correlation Spectroscopy

Regine Choe, Turgut Durduran, So Hyun Chung, Soren D. Konecky, Saurav Pathak, Han Y. Ban, David R. Busch, Erin M. Buckley, Meeri N. Kim, Angela DeMichele, Carolyn Mies, Mark A. Rosen, Mitchell D. Schnall, and Arjun G. Yodh
BSuB2 Biomedical Optics (BIOMED) 2010

Diffuse correlation spectroscopy and tomography for longitudinal monitoring of blood flow changes induced by chemotherapy in breast cancer xenografts

Regine Choe, Gabriel Ramirez, Ashley R. Proctor, Songfeng Han, Turgut Durduran, and Edward B. Brown
CTu4A.4 Cancer Imaging and Therapy (Cancer) 2016

Pilot Study of Blood Flow Markers during Neoadjuvant Chemotherapy

Jeffrey M Cochran, So Hyun Chung, Anais Leproux, Wesley B Baker, David R Busch, Bruce J Tromberg, and Arjun G Yodh
OW2D.5 Optical Tomography and Spectroscopy (OT&S) 2018

Select as filters


Select Topics Cancel
© Copyright 2024 | Optica Publishing Group. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.